So grateful to work every day with this incredible crew and to run the MKE Half today with our amazing team! ❤️ Huge kudos to Jennee, Olivia, Blair, Pam, Lauren and Julie(full!), and thanks for Caryn & Amanda for cheering us on 🙌 @blairtilkens @lauren_howard31 🏃♀️👟💙
@HeartToProve@echo_stepbystep Right but the myocardium does not consistently feel the PVcs either. A sick heart can also increase SV after a PVC but you wouldn’t use that for their CO. Just food for thought. Perhaps an AV calcium score is the answer here (new ESC guidelines).
Excited to share our new publication on Ring-Like Enhancement in @IntJCVImaging
Across heterogeneous cohorts, RLE consistently associated with VA and HF events. May represent a high-risk imaging phenotype rather than a disease-specific marker.
https://t.co/CRCiVvybEO
🧠🫀 Using a large RWD, we studied outcomes of LAAO in patients with cardiac amyloidosis + AF.
1-yr outcomes were comparable to non-CA, but CA mirrors higher-risk cohorts → CHA₂DS₂-VASc may underestimate thromboembolic risk.
👉 https://t.co/3RcEBy32Z2
@crfshj@MCWcardiology
Only 3% of patients with recurrent pericarditis receive IL-1 inhibitors—despite strong trial data. Real-world use is rising, but adoption lags. 📊 Our new study in
@AmJMedSci@AllanLKleinMD1#Pericarditis#IL1 https://t.co/adAfsJQwpM